 |
6 Diseases |  |
2 Trials |
|
2 Trials |  |
63 News |  |
| «12 |
- || Mirvaso (brimonidine tartrate) / Galderma
New P3 trial, Patient reported outcomes: Patient-Reported Outcome Of Facial Erythema (PROOF) (clinicaltrials.gov) - Jun 20, 2013
P3, N=92, Completed, Sponsor: Galderma
- |||||||||| Mirvaso (brimonidine tartrate) / Galderma
New P3 trial: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema (clinicaltrials.gov) - Jun 18, 2013
P3, N=84, Not yet recruiting, Sponsor: Galderma R&D
- ||||||| Mirvaso (brimonidine tartrate) / Galderma
Trial completion: Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea (clinicaltrials.gov) - Mar 10, 2013
P3, N=70, Completed, Sponsor: Galderma Laboratories, L.P.
Recruiting --> Completed
- |||||||||| Mirvaso (brimonidine tartrate) / Galderma
New P3 trial: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea (clinicaltrials.gov) - Feb 10, 2013
P3, N=114, Completed, Sponsor: Galderma R&D
- |||||||||| Mirvaso (brimonidine tartrate) / Galderma
New P3 trial: Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea (clinicaltrials.gov) - Aug 6, 2012
P3, N=70, Completed, Sponsor: Galderma Laboratories, L.P.
- ||||||| Mirvaso (brimonidine tartrate) / Galderma
Trial completion: Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (clinicaltrials.gov) - Jul 22, 2012
P3, N=449, Completed, Sponsor: Galderma
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Mirvaso (brimonidine tartrate) / Galderma
Trial completion: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (clinicaltrials.gov) - Feb 14, 2012
P3, N=293, Completed, Sponsor: Galderma
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Mirvaso (brimonidine tartrate) / Galderma
Trial completion: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (clinicaltrials.gov) - Dec 8, 2011
P3, N=260, Completed, Sponsor: Galderma
Active, not recruiting --> Completed Active, not recruiting --> Completed